Doctor profile · Federal record

Dr. Masha Resman, M.D.

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Hospitalist Physician · Internal Medicine Physician · Sugar Land, TX

  • NPI 1013143890
  • Accepts Medicare
  • 17 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1429 Highway 6
Sugar Land, TX 774785134
(832) 500-1320
fax (713) 917-5744

Credentials & registration

NPPES · NUCC
NPI registered
June 2009 — 17 yrs on file
Profile last updated
January 6, 2026
Year of graduation
2009 — 17 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
Texas #Q2375

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1013143890. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
3,163
Distinct HCPCS
10
Medicare allowed
$120,521
HCPCS Description Services Patients Avg allowed
J0897 Injection, denosumab, 1 mg 1,260 14 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 392 206 $126
36415 Insertion of needle into vein for collection of blood sample 267 157 $8
83036 Hemoglobin a1c level 163 91 $10
80053 Blood test, comprehensive group of blood chemicals 154 114 $10
84443 Blood test, thyroid stimulating hormone (tsh) 125 97 $16
84439 Thyroxine (thyroid chemical), free 121 93 $9
99213 Established patient office or other outpatient visit, 20-29 minutes 115 68 $88
80061 Blood test, lipids (cholesterol and triglycerides) 106 81 $13
82043 Urine microalbumin (protein) level 97 76 $6

In context: peer comparison

Among 3 peers in this city , average services per provider: 179. This provider delivers 18× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,246
Transactions
69
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Corcept Therapeutics 12 $2,215.46
Lilly USA, LLC 14 $168.53
Radius Health, Inc. 9 $157.04
Novo Nordisk Inc 8 $148.30
Amgen Inc. 5 $90.21
ABBVIE INC. 4 $84.31
Xeris Pharmaceuticals, Inc. 4 $75.99
Tandem Diabetes Care, Inc. 2 $58.77
Medtronic, Inc. 1 $50.25
Dexcom, Inc. 2 $47.91
Abbott Laboratories 2 $38.07
IBSA Pharma Inc. 2 $36.60
Bayer Healthcare Pharmaceuticals Inc. 2 $31.46
Boehringer Ingelheim Pharmaceuticals, Inc. 1 $23.29
Salix Pharmaceuticals, a division of Bausch Health US, LLC 1 $19.68

By nature of payment

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
$1,820
Food and Beverage
$1,426

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,198
Patients
667
Total drug cost
$1,136,183
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 392 121 $6,270
Metformin Hcl Generic 181 48 $2,349
Ozempic (Semaglutide) Brand 181 46 $311,591
Jardiance (Empagliflozin) Brand 168 52 $249,577
Atorvastatin Calcium Generic 166 55 $2,886
Pioglitazone Hcl Generic 161 58 $3,966
Metformin Hcl Er (Metformin Hcl) Brand 135 45 $1,911
Synthroid (Levothyroxine Sodium) Brand 133 42 $14,466
Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) Brand 125 37 $141,456
Tresiba Flextouch U-100 (Insulin Degludec) Brand 107 30 $106,394

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Masha Resman's medical specialty?
Dr. Masha Resman practices Endocrinology, Diabetes & Metabolism Physician in Sugar Land, TX.
Where does Dr. Masha Resman practice?
Dr. Masha Resman practices at 1429 Highway 6, Sugar Land, TX 774785134. Office phone: 8325001320.
What is Dr. Masha Resman's NPI?
Dr. Masha Resman's National Provider Identifier (NPI) is 1013143890, issued by NPPES.
Does Dr. Masha Resman accept Medicare assignment?
Yes. Dr. Masha Resman accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Masha Resman commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Insertion of needle into vein for collection of blood sample (HCPCS 36415). Source: CMS Medicare Physician & Other Practitioners file.